Bajaj Finserv Healthcare Fund Review – Bajaj Finserv Healthcare Fund Review Direct NFO Open on 06 December 2024 and Close on 20 December 2024. Bajaj Finserv Healthcare Fund Direct NFO Allotment Date is 27 December 2024, and the NFO Type is Open-Ended. NFO Riskometer is Very High Risk, and the Minimum Investment Amount is ₹500. The Minimum SIP Investment Amount is ₹500.
Type of the Scheme
An open ended equity scheme following pharma, healthcare and allied theme.
Scheme Benchmark : BSE Healthcare Total Return Index (TRI)
Bajaj Finserv Healthcare Fund Scheme Benchmark
| Company | Sector |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES | Healthcare |
| CIPLA LTD. | Healthcare |
| DIVIS LABORATORIES LTD. | Healthcare |
| DR.REDDYS LABORATORIES LTD. | Healthcare |
| Max Healthcare Institute Limit | Healthcare |
| APOLLO HOSPITALS ENTERPRISE LT | Healthcare |
| LUPIN LTD. | Healthcare |
| AUROBINDO PHARMA LTD. | Healthcare |
| FORTIS HEALTHCARE LTD. | Healthcare |
| TORRENT PHARMACEUTICALS LTD. | Healthcare |
Bajaj Finserv Healthcare Fund Important Date
| Scheme Offer | Bajaj Finserv Healthcare Fund |
|---|---|
| Offer Price | Rs. 10/- per Unit |
| Type of Scheme | An open-ended |
| Open Date | 06 Dec 2024 |
| Close Date | 20 Dec 2024 |
| Allotment Date | 27 Dec 2024 |
| Category | Thematic Fund |
| Min Inv ₹ | ₹500 |
| Lock in Period | N/A |
| Risk | Very High |
| Scheme Benchmark | BSE Healthcare Total Return Index |
Investment Objective of the Scheme ?
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
Bajaj Finserv Healthcare Fund Other Details
| Exit Load | 1% |
|---|---|
| Exit Load Details | 1% for redemption within 3 Months |
| Entry Load | N/A |
| Stamp Duty | 0.005% |
| Min. Investment | Rs. 500 |
| Min. SIP | Rs. 500 |
Bajaj Finserv Healthcare Fund Asset Allocation
| Instruments | Allocation Min | Allocation Max |
|---|---|---|
| Equity and Equity Related Securities of pharma, healthcare and allied companies | 80% | 100% |
| Equities and Equity related securities of other than pharma, healthcare and allied companies | 0% | 20% |
| Debt and Money Market Instruments and Units of MutualFund schemes | 0% | 20% |
| Units issued by REITs and InvITs | 0% | 10% |
Manager Manage the Scheme?
Fund Manger : Mr. Nimesh Chandan
Qualification : B.Com, MMS (Finance)
Experience :Mr. Nimesh has over 23 years of experience in the Indian Capital Markets. He has spent 17 years in Fund Management- managing and advising domestic and international investors, retail as well as institutional. Prior to joining Bajaj Finserv Asset Management Ltd, he has worked with Canara Robeco Asset Management as Head Investments, Equities (Domestic and Offshore). He has also worked with other asset management companies including Birla Sunlife Asset Management, SBI Asset Management and ICICI Prudential Asset Management.
Fund Manger : Mr. Sorbh Gupta
Qualification : CA, CFA, BCOM
Experience : Mr. Sorbh has over 16 years of experience in the Indian Capital Markets. Since November 2022, he was appointed as Senior Fund Manager – Equity at Bajaj Finserv Asset Management Limited. Prior to joining Bajaj Finserv Asset Management Limited he was associated with Quantum Asset Management Company Private Ltd. He has also worked with other financial Companies such as Siddhesh Capital Markets Pvt. Ltd. & Pranav Securities Pvt. Ltd.
Fund Manger : Mr. Siddharth Chaudhary
Qualification : B. Com, PGPSM from UTI Institute of Capital Markets
Experience : Mr. Chaudhary joined the Company in July 2022 as Senior Fund Manager – Fixed Income. Prior to this he was associated with Sundaram Asset Management Co. Ltd from April 2019 – July 2022 as Head Fixed Income – Institutional Business, from April 2017 – March 2019 as Senior Fund Manager – Fixed Income, from August 2010 – March 2017 as Fund Manager – Fixed Income. During June 2006 – September 2010 he was working as Senior Manager, Treasury Dept in Indian Bank.
Bajaj Finserv Healthcare Fund Index Return
| Index Return | QTD | YTD | 1 Year | 5 Years | 10 Years |
|---|---|---|---|---|---|
| Price Return | 1.13 | 38.40 | 43.76 | 26.27 | 11.31 |
| Total Return | 1.17 | 39.17 | 44.55 | 27.09 | 12.00 |
Where Will the Scheme Invest ?
- Equity and equity related securities including convertible bonds and debentures and warrants carrying the right to obtain equity shares.
- Securities created and issued by the Central and State Governments and/or repos/reverse repos in such Government Securities as may be permitted by RBI (including but not limited to coupon bearing bonds, zero coupon bonds and treasury bills). Securities guaranteed by the Central and State Governments (including but not limited to coupon bearing bonds, zero coupon bonds and treasury bills).
- Debt securities issued by domestic Government agencies and statutory bodies, which may or may not carry a Central/State Government guarantee.
- Corporate debt securities (of both public and private sector undertakings).
- Securities issued by banks (both public and private sector) including term deposits as permitted by SEBI / RBI from time to time and development financial institutions.
- Money market instruments as permitted by SEBI/RBI.
- Securitized Debt.
- The non-convertible part of convertible securities.
- Derivative instruments like Stock/Index Futures, Stock/Index Options, Interest Rate Future, Interest Rate Swap, Forward Rate Agreement and such other derivative instruments permitted by SEBI.
- Cash & cash equivalents.
- Investment in debt instruments having structured obligations / credit enhancements.
- Non-convertible Preference shares.
- Repo transactions in corporate debt securities.
- Units of REITs & InvITs.
- Debt instruments with special features.
- Units of Mutual Funds Schemes/Exchange Traded Funds.
- Any other domestic fixed income securities subject to requisite approvals from SEBI/RBI, if needed.
Also Read: SBI Quant Fund Review
Bajaj Finserv Healthcare Fund Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower- B, Plot 31-32, Gachibowli, Financial
District, Nanakramguda, Serilingampally, Hyderabad500 032, Telangana, India.
Tel No.: +91 40 6716 2222
Website: Www.Kfintech.Com
Email: Hoacfoods.Ipo@Kfintech.Com
Investor Grievance Email:Einward.Ris@Kfintech.Com
Contact Person: Mr. M Murali Krishna
1 thought on “Bajaj Finserv Healthcare Fund Review – Regular Plan”